Refeeding Syndrome in Cancer Patients (NCT02534181) | Clinical Trial Compass
WithdrawnPhase 2
Refeeding Syndrome in Cancer Patients
Stopped: Logistical issues
0Started 2015-07
Plain-language summary
The purpose of this study is to evaluate whether a nutritional strategy is effective in critically ill patients with cancer diagnosed with refeeding syndrome.
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Initiation of any type of nutrition (enteral, parenteral or glucose solution of at least 10% concentration) in the ICU in the last 48 hours;
* Reduction of serum phosphorus to a level below 2.5mg/dL with a drop above 0.5mg/dL compared to a previous measurement;
* Caloric intake greater than 500kcal in the last 24 hours;
* Central venous access for electrolyte replacement;
* Signature of the informed consent form.
Exclusion Criteria:
* Use of enteral or parenteral nutrition before ICU admission;
* Prediction of ICU discharge in the following 2 days;
* End-stage renal disease;
* Admission for diabetic ketoacidosis or hyperosmolar hyperglycemic state;
* Recent treatment of hyperphosphatemia;
* Parathyroidectomy surgery;
* Participation in another study;
* Refusal to participate in the study.